When nebulized, Alpha2EQ® delivers alpha-2 macroglobulin (A2M) directly to the respiratory tract—targeting inflammation at its source. 🔍 Pilot Study Highlights: 📊 34 horses with clinical signs of equine asthma 📅 6 nebulizations every 48 hours Results: ✅ 88.2% success rate – 30 out of 34 horses showed notable improvement ⏳ Lasting impact – Many horses maintained results for up to 6 months ♻️ Ongoing support – Horses needing continued care responded well to monthly maintenance sessions 💡 Nebul